FDA Orange Book
Is there a generic for Quzyttir?
Quzyttir contains cetirizine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Quzyttir (cetirizine). The Orange Book shows its last listed patent expires February 28, 2030.
Run it in Rivvi
Map Quzyttir and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Quzyttir products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, intravenous | 10MG/ML (10MG/ML) | Marketed (Rx) | None | 0 | None |
NDA 211415, held by ESTEVE PHARMACEUTICALS SA. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Quzyttir patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9180090 | February 11, 2030 | Method of use | U-2635 | 211415 |
| 8513259 | February 11, 2030 | Method of use | U-2636 | 211415 |
| 9119771 | February 11, 2030 | Method of use | U-2635 | 211415 |
| 8314083 | February 28, 2030 | Method of use | U-2634 | 211415 |
| 8263581 | February 28, 2030 | Method of use | U-2635 | 211415 |
Quzyttir NDC codes
Questions
Is there a generic for Quzyttir?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Quzyttir (cetirizine). The Orange Book shows its last listed patent expires February 28, 2030.
What is the generic name for Quzyttir?
The active ingredient in Quzyttir is cetirizine, per the FDA Orange Book.
When does the Quzyttir patent expire?
The last patent listed for Quzyttir in the Orange Book expires February 28, 2030. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.